KD Pharma Group announces acquisition of dsm-firmenich’s marine lipids business
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites in Canada and Peru
Groundbreaking collaboration between KD Pharma Group and DUDE CHEM
We are delighted to announce the collaboration between KD Pharma Group and DUDE CHEM, a fast growing deeptech company specialized in green chemistry manufacturing, for an impactful digitalization pilot project.
First place in the AOCS Laboratory Proficiency Program!
We are very proud to announce that our Quality Control team in KD Pharma Bexbach, Germany, has achieved the first place in the AOCS Laboratory Proficiency Program for GOED Nutraceutical Oils!
60% reduction of carbon emissions at our production sites in Germany
Environmental impact and sustainability have always played an important role in the KD Pharma Group's approach to business. Minimizing waste and improving overall efficiency are cornerstones of the organization.
We are pleased to announce the opening of our new R&D laboratory and offices at our world-class synthesis and fractionation facility in Seal Sands, UK.
KD Pharma VP of sales, Uwe Westeppe, was interviewed at DCAT week
KD Pharma is a very dynamic, fast-growing company, that is constantly enlarging its technology toolbox for chemical transformations, purification and separation, and encapsulation under cGMP.
KD PHARMA FURTHER EXPANDS ITS CDMO CAPABILITIES IN THE UK MANUFATURING SITE
BIOGGIO, SWITZERLAND – October 18, 2021 – The KD Pharma Group has completed an expansion of its manufacturing site in Seal Sands, United Kingdom. The new modern plant followed a fast-track build project and triples the capacity of the site.